Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins.
Previously we found that some cyclopentenone prostaglandin derivatives promoted neurite outgrowth from PC12 cells and dorsal root ganglia explants in the presence of nerve growth factor; and so we referred to them as neurite outgrowth-promoting prostaglandins (NEPPs). In this study, NEPPs protected HT22 cells against oxidative glutamate toxicity. NEPP6, one of the most effective promoters of neurite outgrowth in PC12 cells, protected the cells most potently among NEPPs 1--10. Several derivatives, NEPPs 11--19, were newly synthesized based on the chemical structure of NEPP6. NEPP11 had a more potent neuroprotective effect than NEPP6. NEPP11 also prevented the death of cortical neurons induced by various stimuli and reduced ischemic brain damage in mice. Biotinylated compounds of NEPPs were synthesized to investigate their cellular accumulation. NEPP6-biotin protected the cells and emitted potent signals from the cells. In contrast, biotinylated non-neuroprotective derivatives emitted much weaker signals. These results suggest that NEPPs are novel types of neurotrophic compounds characterized by their dual biological activities of promoting neurite outgrowth and preventing neuronal death and that their accumulation in the cells is closely associated with their neuroprotective actions.
Department of Neuroscience, Osaka Bioscience Institute, Suita-shi, Osaka, Japan. tsatoh@obi.or.jp
T
T
Satoh
K
K
Furuta
K
K
Tomokiyo
S
S
Namura
D
D
Nakatsuka
Y
Y
Sugie
Y
Y
Ishikawa
H
H
Hatanaka
M
M
Suzuki
Y
Y
Watanabe
D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D002545:Brain Ischemia / Q000188:drug therapy; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003517:Cyclopentanes / Q000737:chemistry; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D051379:Mice; D008845:Microinjections; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D016501:Neurites / Q000187:drug effects; D009474:Neurons / Q000166:cytology / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D015230:Prostaglandin D2 / Q000031:analogs & derivatives; D011453:Prostaglandins / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D003517:Cyclopentanes; C424427:NEPP11 compound; C424426:NEPP6 compound; C424428:NEPP6-biotin; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D011453:Prostaglandins; D001710:Biotin; C013905:cyclopentenone; D015230:Prostaglandin D2